AKT1 and cancer: Furthermore, we demonstrated that suppressing β5‐integrin expression in cancer cells decreased Src and Akt phosphorylation following treatment with CM from PCs in the presence of TKIs (Figure 4H; Figure S4L, Supporting Information), suggesting the specific role of β5‐integrin in mediating cancer cell sensitivity to TKIs.